152 related articles for article (PubMed ID: 1324645)
1. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis.
Mertens JC; van Barneveld PW; Asin HR; Ligtvoet E; Visser MR; Branger T; Hoepelman AI
Antimicrob Agents Chemother; 1992 Jul; 36(7):1456-9. PubMed ID: 1324645
[TBL] [Abstract][Full Text] [Related]
2. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
Hoepelman AI; Sips AP; van Helmond JL; van Barneveld PW; Neve AJ; Zwinkels M; Rozenberg-Arska M; Verhoef J
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():147-52. PubMed ID: 8396086
[TBL] [Abstract][Full Text] [Related]
3. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
Klietmann W; Cesana M; Rondel RK; Focht J
Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
[TBL] [Abstract][Full Text] [Related]
7. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
Gris P
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
[TBL] [Abstract][Full Text] [Related]
8. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media.
Arguedas A; Emparanza P; Schwartz RH; Soley C; Guevara S; de Caprariis PJ; Espinoza G
Pediatr Infect Dis J; 2005 Feb; 24(2):153-61. PubMed ID: 15702045
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections.
Balmes P; Clerc G; Dupont B; Labram C; Pariente R; Poirier R
Eur J Clin Microbiol Infect Dis; 1991 May; 10(5):437-9. PubMed ID: 1651860
[TBL] [Abstract][Full Text] [Related]
11. Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
Swanson RN; Lainez-Ventosilla A; De Salvo MC; Dunne MW; Amsden GW
Treat Respir Med; 2005; 4(1):31-9. PubMed ID: 15725048
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis.
Chodosh S
Am J Med; 1993 Mar; 94(3A):131S-135S. PubMed ID: 8452169
[TBL] [Abstract][Full Text] [Related]
13. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
[TBL] [Abstract][Full Text] [Related]
15. A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
Rademaker CM; Sips AP; Beumer HM; Hoepelman IM; Overbeek BP; Möllers MJ; Rozenberg-Arska M; Verhoef J
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():75-81. PubMed ID: 2286595
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study.
Davies BI; Maesen FP; Gubbelmans R
J Antimicrob Chemother; 1989 May; 23(5):743-51. PubMed ID: 2547747
[TBL] [Abstract][Full Text] [Related]
18. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
Daniel R
J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
O'Doherty B; Daniel R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290
[TBL] [Abstract][Full Text] [Related]
20. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections.
Roord JJ; Wolf BH; Gossens MM; Kimpen JL
Antimicrob Agents Chemother; 1996 Dec; 40(12):2765-8. PubMed ID: 9124837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
